A study tells that majority of glaucoma patients who received combined deep sclerectomy and cataract surgery maintained a lower IOP at nearly 10 years follow-up with a minimum number of complications.
Recently the Eye-care giant Alcon Laboratories is shelving a long-studied drug that initially had been considered promising for treating age-related macular degeneration and glaucoma.
Glaucoma is the most common disease of eye after cataract. Many of you must be waiting to know this disease in a more detailed manner, and ofcourse in simpler language which often other medical journal articles would not provide you. So in next few minutes browse down the lines, and get to know what glaucoma is? Therefore from the next time onwards you dont mix up with the basic concept regarding glaucoma.
Glaucoma is a familiar name among eye diseases. So lets discuss about a typical type of glaucoma in this edition.
Checkout if your drainage system of eye working properly :
Patients of open-angle glaucoma, secondary glaucoma, and preoperatively acute angle-closure glaucoma are no longer required to suffer from surgery delays due to high intraocular pressure(IOP). Diamox, X-GEN Pharmaceuticals has devised a new adjunctive treatment for lowering IOP. Full article »